Treatments for juvenile idiopathic arthritis
SHTAC is assessing the clinical-effectiveness and cost-effectiveness of abatacept, adalimumab, etanercept and tocilizumab for the treatment of juvenile idiopathic arthritis.
Tests for diagnosing pre-eclampsia
SHTAC is critically evaluating the clinical accuracy and cost-effectiveness of tests for diagnosing pre-eclampsia.
SHTAC is critically evaluating the clinical accuracy and cost-effectiveness of tests for diagnosing pre-eclampsia
SHTAC publishes new report on treatments for idiopathic pulmonary fibrosis
NICE issues guidance on simeprevir for chronic hepatitis C
SHTAC's expertise in evidence synthesis has allowed us to develop training courses in systematic reviews and health economic evaluations.
SHTAC is involved in research addressing major policy questions on the use of drugs, devices, procedures, screening programmes, health promotion and public health and other interventions.